Dexcom
A Senior R&D scientist on Dexcom’s Therapeutics, Diagnostics, and Insights (TDI) team focused on developing algorithmic and model-based features that enhance continuous glucose monitoring products. The role centers on advancing personalized diagnostics, prescriptive therapeutics, and metabolic-health insights across the spectrum from pre-diabetes to insulin-dependent diabetes. The position supports translating R&D prototypes into clinical and commercial software within a fast-paced, innovation-driven organization.
Headquarters
San Diego, California, United States
Company Size
10001+ employees
Founded
1999
Dexcom Continuous Glucose Monitoring is simplifying diabetes management with a small device, accurate real-time glucose readings, and proven results. No fingersticks or scanning.†
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Dexcom.
Dexcom G7 study: weight benefits and fewer ketoacidosis hospital visits
1 day ago